This site requires Javascript to be enabled on many pages
π½οΈ citalopram hydrobromide,(prescription)
AI Engines For more Details:
Perplexity
Kagi Labs
You
(adeprenal, alcytam, apo-citalopram, arpolax, aurex, celopram, ceropram, cimal, cipram, cipramax, cipramil, ciprotan, ciral, citabax, citahexal, citalanorm genericon, citalop, citalopram, citalopram actavis, citalopram alpharma, citalopram cipla, citalopram hexal, citalopram l.ch., citalopram mintlab, citalopram opko, citalopram orifarm, citalopram orion, citalopram vitabalans, citalopram-ct, citalopram-remedica, citapram, citolixin, citomax, città, c-talo, cyteras, depram, eslopram, humorap, hydertan, laira, lecital, lopram, lowdep, lupram, madam, malicon, oropram, pms citalopram, pram, pratric, procimax, puracit, ramdeep, sedopram, seropram, timopram, vodelax, zentius, zetalo, zyloram, abbott-citalopram, abgenix, actipram, adco-talomil, alepram, alopra, ansiben, antidepressa, apo-cital, arrow citalopram, auro-citalopram, austell-citalopram, bestilo, bio citalopram, bivien, calton, celapram, celexa, celica, celius, cilate, cilift, cilodral, cilopa, ciloram, cinapen, cinavol, ciprager, cipraned, citagen, cital, citalec, citalec zentiva, citalodep, citalogamma, citalogen, citalon, citalopram - 1 a pharma, citalopram +pharma, citalopram 1a pharma, citalopram abc, citalopram abz, citalopram accord, citalopram actor, citalopram al, citalopram almus, citalopram alter, citalopram alternova, citalopram aphar, citalopram apotex, citalopram arcana, citalopram aristo, citalopram arrow, citalopram aurobindo, citalopram azevedos, citalopram beta, citalopram bexal, citalopram biogaran, citalopram bluefish, citalopram bmm pharma, citalopram cf, citalopram cinfa, citalopram cnspharma, citalopram cristers, citalopram ct, citalopram davur, citalopram dura, citalopram edigen, citalopram eg, citalopram evolugen, citalopram g.l., citalopram generichealth, citalopram genericon, citalopram helvepharm, citalopram hennig, citalopram holsten, citalopram isomed, citalopram kent, citalopram kern pharma, citalopram korhispana, citalopram lareq, citalopram mabo, citalopram molteni, citalopram mylan, citalopram mylan generics, citalopram normon, citalopram ortodrol, citalopram pch, citalopram pensa, citalopram pfizer, citalopram pharmagenus, citalopram placasod, citalopram pliva, citalopram q-pharm, citalopram qualigen, citalopram ranbaxy, citalopram ranbaxygen, citalopram ratiopharm, citalopram rivopharm, citalopram sandoz, citalopram sanis health, citalopram spirig hc, citalopram stada, citalopram streuli, citalopram tarbis, citalopram teva, citalopram teva sante, citalopram teva-rimafar, citalopram ur, citalopram uxa, citalopram vir, citalopram winthrop, citalopram zentiva, citalopram zentiva italia, citalopram zydus, citalopram-ga, citalopram-hormosan, citalopram-mepha, citalopram-neuraxpharm, citalopram-ratiopharm, citalopram-teva, citalopram-winthrop, citalo-q, citalostad, citalvir, citao, citaxin, citesint, citexam, citol, citolap, citom, citox, citrex, citronil, claropram spirig hc, copsam, cortran, ctp, dalsan, decilop, depramil, depretal, drl-citalopram, ecloram, elopram, exenadil, felipram, feliz 20, frimaind, galopran, goldamit, kitapram, linisan, lodeprem, lopracil, lopralex, lopraxer, mai ke wei, maxapran, pharmacor citalopram, pms-citalopram, pralotam, pramcil, pramital, prefucet, prepram, pricital, prisdal, psiconor, ran-citalo, relapaz, renevil, riva-citalopram, ropramin, sandoz citalopram, selon, sepram, seregra, seror, setronil, siloam, sitalo, talosin, te lin na, teva-citalopram, ultidep, varom, vesema, wang you, xadorek, yi tai na, yitean, zanipram, zeclicid, zoxipan, acelopam, a-depress-therapy, atinorm, cilopress, citalgert, citalopram almus pharma, citalopram doc, citalopram doc generici, citalopram dr. reddy's, citalopram eurogenerici, citalopram focus, citalopram pensa pharma, citalopram ranbaxy italia, citalopram ratiopharm italia, citalopram rosemont, citalopram sandoz bv, citalopram sandoz gmbh, citalopram sigmatau generics, citaloprol, depran, kaidor, kylipram, loptar, percitale, ricap, sintopram, sotovon, tasonade)
Impacted of citalopram hydrobromide,(prescription) On Probiotics
Rank
Probiotic
Impact
species
Akkermansia muciniphila
Reduces
species
Bifidobacterium adolescentis
Reduces
species
Escherichia coli
Reduces
species
Lacticaseibacillus paracasei
Reduces
Bacteria Impacted by citalopram hydrobromide,(prescription)
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species , that would be the genus that is belongs to and the strains in the species.
π§?
Taxonomy
Rank
Effect
Citations
Notation
Akkermansia
genus
Decreases
👪 Source Study
Phocaeicola
genus
Decreases
👪 Source Study
Lacrimispora
genus
Decreases
👪 Source Study
Fusobacterium
genus
Decreases
👪 Source Study
Periodontal disease, Lemierre syndrome, skin ulcers
Bacteroides
genus
Decreases
👪 Source Study
Dorea
genus
Decreases
👪 Source Study
Blautia
genus
Decreases
👪 Source Study
Veillonella
genus
Decreases
👪 Source Study
Thomasclavelia
genus
Decreases
👪 Source Study
Mediterraneibacter
genus
Decreases
👪 Source Study
Lacticaseibacillus
genus
Decreases
👪 Source Study
Odoribacter
genus
Decreases
👪 Source Study
Segatella
genus
Decreases
👪 Source Study
Eggerthella
genus
Decreases
👪 Source Study
Lachnospira
genus
Decreases
👪 Source Study
Agathobacter
genus
Decreases
👪 Source Study
Bifidobacterium
genus
Decreases
👪 Source Study
unclassified Robinsoniella
no rank
Decreases
⚗️ Source Study
unclassified Fusobacterium
no rank
Decreases
⚗️ Source Study
unclassified Negativicoccus
no rank
Decreases
⚗️ Source Study
Eggerthellales
order
Decreases
⚗️ Source Study
Akkermansia muciniphila
species
Decreases
📓 Source Study
Phocaeicola vulgatus
species
Decreases
📓 Source Study
Lacrimispora saccharolytica
species
Decreases
📓 Source Study
Escherichia coli
species
Decreases
📓 Source Study
Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Escherichia coli
species
Decreases
📓 Source Study
Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Staphylococcus aureus
species
Decreases
📓 Source Study
Skin infections, sinusitis, food poisoning
Staphylococcus aureus
species
Decreases
📓 Source Study
Skin infections, sinusitis, food poisoning
Bacteroides thetaiotaomicron
species
Decreases
📓 Source Study
Fusobacterium nucleatum
species
Decreases
📓 Source Study
Infectious bacteria
Bacteroides fragilis
species
Decreases
📓 Source Study
H02076 Bacteroides infection
Dorea formicigenerans
species
Decreases
📓 Source Study
Anaerofustis stercorihominis
species
Decreases
⚗️ Source Study
Asaccharospora irregularis
species
Decreases
⚗️ Source Study
Blautia obeum
species
Decreases
📓 Source Study
Negativicoccus sp. S5-A15
species
Decreases
⚗️ Source Study
Veillonella parvula
species
Decreases
📓 Source Study
Paraprevotella clara
species
Decreases
⚗️ Source Study
Slackia sp. NATTS
species
Decreases
⚗️ Source Study
Bacteroides uniformis
species
Decreases
📓 Source Study
Infectious bacteria
Thomasclavelia ramosa
species
Decreases
📓 Source Study
Bacteroides caccae
species
Decreases
📓 Source Study
Pseudoflavonifractor capillosus
species
Decreases
⚗️ Source Study
[Collinsella] massiliensis
species
Decreases
⚗️ Source Study
[Ruminococcus] gnavus
species
Decreases
📓 Source Study
Parvibacter caecicola
species
Decreases
⚗️ Source Study
Lacticaseibacillus paracasei
species
Decreases
📓 Source Study
Odoribacter splanchnicus
species
Decreases
📓 Source Study
Segatella copri
species
Decreases
📓 Source Study
Over 70%ile Indicator of mycotoxin present
Eggerthella lenta
species
Decreases
📓 Source Study
Lachnospira eligens
species
Decreases
📓 Source Study
Agathobacter rectalis
species
Decreases
📓 Source Study
Bifidobacterium adolescentis
species
Decreases
📓 Source Study
Coriobacterineae
suborder
Decreases
⚗️ Source Study
Fusobacterium nucleatum subsp. nucleatum
subspecies
Decreases
👶 Source Study
Lacticaseibacillus paracasei subsp. paracasei
subspecies
Decreases
👶 Source Study
Chlamydiae/Verrucomicrobia group
superphylum
Decreases
⚗️ Source Study
Impact of citalopram hydrobromide,(prescription) on Conditions from US National Library of Medicine
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups.
We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition
Positive Impact
Negative Impact
Benefit Ratio Impact
Acne
0
0
ADHD
0.4
0
0
Age-Related Macular Degeneration and Glaucoma
0.1
0.1
Allergic Rhinitis (Hay Fever)
0.2
0
0
Allergies
1.2
1.2
0
Allergy to milk products
0.6
0
0
Alopecia (Hair Loss)
0.2
0.2
Alzheimer's disease
1.4
0.6
1.33
Amyotrophic lateral sclerosis (ALS) Motor Neuron
1.5
1.2
0.25
Ankylosing spondylitis
0.8
0.4
1
Anorexia Nervosa
0.2
-0.2
Antiphospholipid syndrome (APS)
1
1
Asthma
0.5
1.7
-2.4
Atherosclerosis
0.2
0.5
-1.5
Atrial fibrillation
0.4
0.2
1
Autism
2.4
2.5
-0.04
Barrett esophagus cancer
0.2
0.2
Bipolar Disorder
0.1
0.1
0
Brain Trauma
0
0.1
0
Carcinoma
0.4
0.4
0
Celiac Disease
1.4
0.8
0.75
Cerebral Palsy
0.4
0.2
1
Chronic Fatigue Syndrome
0.7
1.5
-1.14
Chronic Kidney Disease
0.3
0
0
Chronic Lyme
0.1
-0.1
Chronic Obstructive Pulmonary Disease (COPD)
0.2
0
0
Chronic Urticaria (Hives)
0.6
1
-0.67
Coagulation / Micro clot triggering bacteria
1
0.1
9
Colorectal Cancer
1.4
0
0
Constipation
0.8
0.1
7
Coronary artery disease
0.1
0.2
-1
COVID-19
2.9
3.6
-0.24
Crohn's Disease
2.3
1.2
0.92
cystic fibrosis
0.5
0.1
4
deep vein thrombosis
1
1
Depression
1.9
1.5
0.27
Dermatomyositis
0
0
Eczema
0.2
0.3
-0.5
Endometriosis
0.8
0.1
7
Eosinophilic Esophagitis
0.1
0.1
0
Epilepsy
1
1.2
-0.2
Fibromyalgia
0.3
0.3
0
Functional constipation / chronic idiopathic constipation
2.1
0.6
2.5
gallstone disease (gsd)
0.3
0.2
0.5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus
1.2
0.2
5
Generalized anxiety disorder
0.8
0.1
7
Graves' disease
0.1
0.2
-1
Halitosis
0.4
0.4
Hashimoto's thyroiditis
0.7
0.1
6
Hidradenitis Suppurativa
0.1
0.1
0
Histamine Issues,Mast Cell Issue, DAO Insufficiency
1
0.2
4
hypercholesterolemia (High Cholesterol)
0.1
0.7
-6
hyperglycemia
1.2
-1.2
Hyperlipidemia (High Blood Fats)
0.3
0.3
hypersomnia
0.1
-0.1
hypertension (High Blood Pressure
0.5
0.9
-0.8
Hypothyroidism
0.1
-0.1
Hypoxia
0.5
0.5
IgA nephropathy (IgAN)
0.8
-0.8
Inflammatory Bowel Disease
1.2
1.6
-0.33
Insomnia
0.2
0.1
1
Intelligence
0.1
0
0
Intracranial aneurysms
0.2
0.2
Irritable Bowel Syndrome
2
1.7
0.18
Liver Cirrhosis
1.5
0.7
1.14
Long COVID
2.4
1.3
0.85
Low bone mineral density
0
0
Lung Cancer
0.1
0.9
-8
ME/CFS with IBS
0.5
-0.5
ME/CFS without IBS
0.3
0.5
-0.67
Menopause
0
0
Metabolic Syndrome
1.9
2.7
-0.42
Mood Disorders
2.7
1.5
0.8
multiple chemical sensitivity [MCS]
0.4
0.1
3
Multiple Sclerosis
1.4
0.5
1.8
Multiple system atrophy (MSA)
1
0.1
9
Neuropathy (all types)
0.4
0.4
neuropsychiatric disorders (PANDAS, PANS)
0.6
0.6
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic
0.2
1.2
-5
NonCeliac Gluten Sensitivity
0
0
Obesity
1.3
1.7
-0.31
obsessive-compulsive disorder
2
1.2
0.67
Osteoarthritis
0.4
0.4
Osteoporosis
0.2
0.9
-3.5
pancreatic cancer
0.1
0.1
Parkinson's Disease
1.5
0.6
1.5
Polycystic ovary syndrome
0.9
0.4
1.25
Postural orthostatic tachycardia syndrome
0
0
Premenstrual dysphoric disorder
0.1
0.1
primary biliary cholangitis
0.1
0.1
0
Psoriasis
2
0.9
1.22
rheumatoid arthritis (RA),Spondyloarthritis (SpA)
1.2
0.8
0.5
Rosacea
0
0
Schizophrenia
1.2
0.1
11
scoliosis
0
0
Sjögren syndrome
0.4
0.5
-0.25
Sleep Apnea
0.2
0.2
0
Small Intestinal Bacterial Overgrowth (SIBO)
0.6
0.6
Stress / posttraumatic stress disorder
1.2
0.8
0.5
Systemic Lupus Erythematosus
0.9
0.2
3.5
Tic Disorder
0.7
0.2
2.5
Tourette syndrome
0.3
0.1
2
Type 1 Diabetes
1.2
0.7
0.71
Type 2 Diabetes
2.6
3.6
-0.38
Ulcerative colitis
0.9
2.1
-1.33
Unhealthy Ageing
1.7
0.4
3.25
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance.
Special thanks to Oliver Luk, B.Sc. (Biology) from
BiomeSight for spot checking the coding of data from the US National Library of Medicine
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence ) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.